THURSDAY, June 16, 2022 (HealthDay News) — Managing epilepsy is an increasingly expensive process in the United States, with prices of brand-name anti-seizure drugs nearly quadrupling over eight years, a new study finds. From 2010 to 2018, the cost of brand-named epilepsy drugs, including meds like Vimpat (lacosamide), rose 277%Continue Reading
THURSDAY, June 16, 2022 (HealthDay News) — Adult flu shots have slumped in states with low COVID-19 vaccination rates, suggesting that COVID-19 vaccination behavior may have spilled over to flu-vaccine behavior, new research indicates. University of California, Los Angeles researchers point to declining trust in public health agencies caused byContinue Reading
WEDNESDAY, June 15, 2022 (HealthDay News) — An advisory panel to the U.S. Food and Drug Administration voted unanimously on Wednesday to recommend the emergency use of both the Pfizer and Moderna COVID-19 vaccines for the country’s youngest children. The approvals come not a moment too soon: More than twoContinue Reading
WEDNESDAY, June 15, 2022 (HealthDay News) — The U.S. Food and Drug Administration’s vaccine advisory panel voted unanimously on Tuesday to recommend the agency approve the emergency use of Moderna’s COVID-19 vaccine in children aged 6 to 17. Despite the unanimous support, some panel members worried that trials of theContinue Reading
TUESDAY, June 14, 2022 (HealthDay News) — The U.S. Food and Drug Administration’s vaccine advisory panel will decide on Tuesday whether to recommend the agency approve the emergency use of Moderna’s COVID-19 vaccine in children aged 6 to 17. The panel will analyze Moderna’s two-dose vaccine for children aged 6Continue Reading
MONDAY, June 13, 2022 (HealthDay News) — Many may consider an episode of binge drinking — defined as 5 or more drinks on one occasion — as just being harmless fun. But a new study suggests that even moderate drinkers who indulge in binge drinking can suffer lasting consequences. ResearchersContinue Reading
MONDAY, June 13, 2022 (HealthDay News) — An experimental drug for the neurological disorder ALS was approved in Canada on Monday, but an ongoing evaluation of the treatment by the U.S. Food and Drug Administration has raised questions about its effectiveness. A condition of Health Canada’s approval of Albrioza (AMX0035)Continue Reading
MONDAY, June 13, 2022 (HealthDay News) — Antibody levels suggest that three doses of Pfizer’s pediatric COVID vaccine help guard children under 5 against infection, a new analysis from the U.S. Food and Drug Administration shows. It was posted online Sunday ahead of an FDA advisory panel meeting scheduled forContinue Reading
MONDAY, June 13, 2022 (HealthDay News) — It’s OK to drink coffee soon after taking a liquid thyroid medication, a new study finds. Current product labels and treatment guidelines recommend patients take thyroid hormone replacement therapy on an empty stomach, but this new research shows that absorption of liquid levothyroxineContinue Reading
FRIDAY, June 10, 2022 (HealthDay News) — Pharmacies and states have ordered millions of doses of the Pfizer and Moderna COVID vaccines for children younger than 5 in advance of possible U.S. authorization of the shots next week, the Biden administration said Thursday. Senior officials said that 5 million dosesContinue Reading